Work

Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer

Year: 2020

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.02.017

Authors: G. Lamberti, L.F. Spurr, Y. Li, B. Ricciuti, G. Recondo, R. Umeton, M. Nishino, L.M. Sholl, M.L. Meyerson, A.D. Cherniack, M.M. Awad

Institutions: Harvard University, Dana-Farber Cancer Institute, Broad Institute, Massachusetts Institute of Technology, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, AstraZeneca, Syndax Pharmaceuticals, Genentech, Daiichi Sankyo Europe

OpenAlex ID: W3012365695

FWCI: 5.454

Cites: 22

Cited by: 98

Related to: 10